ArticleInvestigational new drugs2020

Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.

Marcus Noel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.